Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
 BACK TO LIST

European Patient Summary

Patient
Name: Hermighausen, Henryk
DOB: 07-JAN-1964 (Age: 62)
Gender: male
ID: 8946-366848-6 (ECI)
Author
Postma, Iris
Patient summary Document
European Patient Summary
Report Date: 24-FEB-2025

Problem list

Condition Onset Date / Period Status
Hyperlipidemia 24-Feb-2025 active
Metabolic syndrome X 13-Feb-2023 active
Essential hypertension 01-Feb-2021 active
Anemia 10-Jan-2011 active
Acute infective cystitis 11-Jan-2025 - 12-Jan-2025 inactive
COVID-19 02-Feb-2021 - 10-Mar-2021 inactive
Viral sinusitis 09-Jan-2020 - 04-Feb-2020 inactive

Medication list

Medication Since Form Dosage Reason
Simvastatin 10 mg oral tablet 2025-03-17 - 1 tablet (10 mg) by mouth once daily Hyperlipidemia
Amlodipine (as amlodipine besylate) 2.5 mg oral tablet 2025-02-24 - 1 tablet (2.5 mg) by mouth once daily Essential hypertension (disorder)
Hydrochlorothiazide 25 mg oral tablet 2025-02-24 - 1 tablet (25 mg) by mouth once daily Essential hypertension (disorder)
Ferrous sulfate 325 mg prolonged-release oral tablet 2011-01-18 - 1 tablet (325 mg) by mouth once daily -

Immunizations list

Vaccine Date
Influenza virus antigen only vaccine product 24-Feb-2025
Clostridium tetani toxoid antigen adsorbed only vaccine product 19-Feb-2024
SARS-CoV-2 mRNA vaccine 28-Jun-2021

Procedure History list

No known procedures

Allergies and Intolerances

No known allergies or intolerances

Care Plan

Active Planned Care / Goals Start Date Reason
Hyperlipidemia clinical management plan 17-Mar-2025 Hyperlipidemia (disorder)
  • Achieve LDL cholesterol less than 2.6 mmol/L
  • Achieve total cholesterol less than 5.2 mmol/L
  • Achieve triglycerides less than 1.7 mmol/L
  • Achieve HDL cholesterol greater than 1.0 mmol/L
Lifestyle education regarding hypertension 01-Feb-2021 Essential hypertension (disorder)
  • Maintain blood pressure below 130/80 mmHg through lifestyle modifications.
  • Patient will demonstrate understanding of dietary, exercise, and lifestyle changes to manage hypertension.
Diabetes self management plan 01-Jan-2007 Prediabetes (finding)
  • Maintain hemoglobin A1c below 5.7% through lifestyle modification and self-management.
  • Achieve and maintain a healthy body weight to reduce risk of diabetes progression.
  • Maintain blood pressure below 130/80 mmHg through lifestyle changes.
  • Maintain LDL cholesterol below 100 mg/dL to reduce cardiovascular risk.
Immunization Recommendation Due Date Reason
Influenza virus antigen only vaccine product 01-Oct-2026 Annual seasonal influenza vaccination

Vital Signs

Vital Signs 2025-02-24 2024-02-19
Body Height 176.5 cm 176.5 cm
Pain severity - 0-10 verbal numeric rating [Score] - Reported 2 {score} 2 {score}
Body Weight 86.5 kg 86.5 kg
Body mass index (BMI) [Ratio] 27.8 kg/m2 27.8 kg/m2
Heart rate 85 /min 81 /min
Respiratory rate 14 /min 13 /min
Blood pressure panel with all children optional 100 mm[Hg] 104 mm[Hg]

Relevant diagnostic tests/laboratory data

Recent Lab Observations 24-FEB-2025 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.3 H 4.8 - 5.9 %
Cholesterol [Mass/volume] in Serum or Plasma 229.5 H 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 324.4 H 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 119.9 H 0 - 100 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 60.7 H 40 - 60 mg/dL
Glucose [Mass/volume] in Blood 75.7 70 - 100 mg/dL
Urea nitrogen [Mass/volume] in Blood 15.6 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 2.6 H 0.6 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 9.5 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 142.4 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 5.2 H 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 110.4 H 98 - 107 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 21.5 L 22 - 29 mmol/L
Protein [Mass/volume] in Serum or Plasma 6.8 6.6 - 8.3 g/dL
Albumin [Mass/volume] in Serum or Plasma 3.6 3.5 - 5.0 g/dL
Globulin [Mass/volume] in Serum by calculation 3.4 L 25 - 35 g/L
Bilirubin.total [Mass/volume] in Serum or Plasma 0.6 0.2 - 1.2 mg/dL
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 41.2 39 - 117 U/L
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 30.5 10 - 40 U/L
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 28.6 10 - 40 U/L
Glucose [Mass/volume] in Blood 75.7 70 - 100 mg/dL
Urea nitrogen [Mass/volume] in Blood 15.6 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 1.1 0.6 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 9.5 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 142.4 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 5.2 H 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 110.4 H 98 - 107 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 21.5 L 22 - 29 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 159.6 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 102.8 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 81.3 0 - 100 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 57.8 40 - 60 mg/dL
Leukocytes [#/volume] in Blood by Automated count 6.9 4.0 - 11.0 10*3/uL
Erythrocytes [#/volume] in Blood by Automated count 5.0 4.3 - 5.7 10*6/uL
Hemoglobin [Mass/volume] in Blood 15.0 13.5 - 17.5 g/dL
Hematocrit [Volume Fraction] of Blood by Automated count 35.4 L 37 - 51 %
MCV [Entitic mean volume] in Red Blood Cells by Automated count 92.5 80 - 100 fL
MCH [Entitic mass] by Automated count 32.2 27 - 33 pg
MCHC [Entitic Mass/volume] in Red Blood Cells by Automated count 34.3 32 - 36 g/dL
Erythrocyte distribution width [Entitic volume] by Automated count 41.4 36 - 48 fL
Platelets [#/volume] in Blood by Automated count 213.1 150 - 450 10*3/uL
Platelet distribution width [Entitic volume] in Blood by Automated count 477.1 H 9.4 - 12.3 fL
Platelet [Entitic mean volume] in Blood by Automated count 9.7 7.4 - 10.4 fL

Device Use

Device Date (since)
Blood glucose meter (physical object) 01-Jan-2007